By Ainvest in magic-signal — 17 Jun 2025

🎯 Magic Signal Daily Report - 2025-06-18

⚠️

Investment Disclaimer: This report is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Please consult with a financial advisor before making investment decisions.

💡

How to Read the Heatmaps: The "1D", "7D", and "30D" columns represent different holding periods. The win rates shown are from backtests of buying at the opening price on the day after a signal and selling at the close 1, 7, or 30 days later.

📈 Bull Stock Signal Performance

Ticker

30D

Click any ticker or win rate to view detailed charts on AInvest.

📉 Bear Stock Signal Performance

Ticker

30D

Click any ticker or win rate to view detailed charts on AInvest.

📊 ETF Signal Performance

ETF

30D

Click any ETF ticker or win rate to view detailed information.

📊 Daily Summary Statistics

Bull Stock Signals 4

Bear Stock Signals 18

ETF Signals 2

Avg. Bull Win Rate (7D) 60.8%

Avg. Bear Win Rate (7D) 58.8%

Avg. ETF Win Rate (7D) 59.8%

Unlock Full Magic Signal Access

Bull Stock Signals - Positive Momentum Plays

FWONK - Formula One Group (Liberty Media)

Market Cap: $24.3B | Win Rates: 1D: 52%, 7D: 58%, 30D: 68%

Formula One Group represents Liberty Media's ownership stake in the Formula 1 racing franchise 1 2. This is a pure play on the growing global popularity of Formula 1, especially in the US market. The improving win rates over longer timeframes (68% at 30 days) suggest this entertainment powerhouse has solid fundamentals backing its momentum. For retail investors, FWONK offers exposure to premium sports entertainment without the volatility of traditional media stocks.

CIG.C - CEMIG (Brazilian Utility)

Market Cap: $8.2B | Win Rates: 1D: 63%, 7D: 48%, 30D: 52%

CEMIG is Brazil's major electric utility company, operating extensive hydroelectric, wind, and solar power generation facilities 3 4. Despite the mixed 7-day performance, the strong 1-day signals suggest short-term trading opportunities. Brazilian utilities can be volatile due to currency fluctuations and regulatory changes, but CEMIG's diversified energy portfolio and strong dividend yield (12.02%) make it attractive for income-focused retail investors 4.

STRL - Sterling Infrastructure

Market Cap: $5.8B | Win Rates: 1D: 67%, 7D: 67%, 30D: 35%

Sterling Infrastructure specializes in heavy civil construction, focusing on transportation, e-infrastructure, and building solutions 5. The strong short-term signals (67% win rate for both 1D and 7D) indicate near-term momentum, but the drop to 35% at 30 days suggests caution for long-term holds. This infrastructure play benefits from government spending on roads, bridges, and data centers, making it a solid cyclical investment for retail investors timing infrastructure cycles.

SANM - Sanmina Corporation

Market Cap: $4.6B | Win Rates: 1D: 38%, 7D: 71%, 30D: 68%

Sanmina provides integrated manufacturing solutions and recently made headlines with its $3 billion acquisition of ZT Systems' manufacturing operations from AMD 6. The weak 1-day performance but strong 7D and 30D win rates suggest this is a value play that rewards patient investors. The company's expansion into AI infrastructure manufacturing positions it well for the ongoing data center boom, making it an interesting long-term play for retail investors betting on AI infrastructure growth.

Bear Stock Signals - Short-Term Trading Opportunities

XCUR - Exicure (Biotech)

Market Cap: $66.1M | Win Rates: 1D: 60%, 7D: 60%, 30D: 48%

Exicure is a clinical-stage biotech developing nucleic acid therapies using proprietary Spherical Nucleic Acid technology 7 8. The consistent 60% win rates for short-term trades suggest good momentum signals, but the declining 30-day performance reflects typical biotech volatility. Recent Nasdaq compliance issues add risk 7. This is a speculative play suitable only for retail investors comfortable with high-risk biotech investments.

SCYX - SCYNEXIS (Antifungal Developer)

Market Cap: $34.7M | Win Rates: 1D: 57%, 7D: 48%, 30D: 57%

SCYNEXIS develops antifungal treatments, particularly for serious fungal infections 9. The mixed signals across timeframes reflect the challenges facing small biotech companies. With revenue declining 81.3% year-over-year and continued losses, this is purely a speculative momentum play 10. Retail investors should approach with extreme caution and only allocate small position sizes.

MGX - Metagenomi (Gene Editing)

Market Cap: $65.8M | Win Rates: 1D: 60%, 7D: 60%, 30D: 80%

Metagenomi focuses on precision gene-editing technologies and therapies 11. The impressive 80% win rate at 30 days suggests strong underlying momentum despite the early-stage nature of the company. Recent promising results in hemophilia A studies provide fundamental support 11. This represents a higher-risk, higher-reward play in the gene therapy space for retail investors with risk tolerance for emerging biotech.

DMAC - DiaMedica Therapeutics

Market Cap: $178.8M | Win Rates: 1D: 80%, 7D: 80%, 30D: 40%

DiaMedica develops novel recombinant proteins, particularly DM199 for stroke and kidney disease 12. The exceptional short-term win rates (80% for both 1D and 7D) but weak 30-day performance suggest strong momentum trading opportunities but potential fundamental concerns. Recent analyst upgrades and buy ratings provide some confidence 12. Suitable for retail investors seeking short-term biotech momentum plays.

LAZR - Luminar Technologies (LiDAR)

Market Cap: $174.4M | Win Rates: 1D: 57%, 7D: 43%, 30D: 64%

Luminar provides LiDAR sensors and software for autonomous vehicles 13. The company faces significant challenges including recent CEO departure, ongoing investigations, and massive cash burn 13. The mixed signals reflect the uncertainty in autonomous vehicle adoption timelines. While the technology is promising, this is a high-risk play suitable only for retail investors betting on the long-term autonomous vehicle revolution.

ETF Signals - Diversified Exposure

WCBR - WisdomTree Cybersecurity ETF

Market Cap: $131.8M | Win Rates: 1D: 75%, 7D: 62%, 30D: 56%

This ETF provides broad exposure to cybersecurity companies globally 14 15. The strong 1-day signals suggest good momentum in the cybersecurity sector. Top holdings include CrowdStrike, SentinelOne, and other leading security firms 15. For retail investors wanting cybersecurity exposure without single-stock risk, WCBR offers a diversified approach to this growing sector.

CIBR - First Trust Nasdaq Cybersecurity ETF

Market Cap: $9.5B | Win Rates: 1D: 66%, 7D: 57%, 30D: 66%

CIBR tracks the Nasdaq CTA Cybersecurity Index, focusing on US cybersecurity companies 16 17. The consistent performance across timeframes suggests stable momentum in the cybersecurity space. As the larger and more liquid cybersecurity ETF, CIBR provides retail investors with better liquidity and tighter spreads compared to smaller alternatives.

Key Takeaways for Retail Investors

Short-Term Momentum: Focus on stocks with consistent win rates across 1D and 7D timeframes, such as STRL and DMAC for quick trades.

Long-Term Value: Consider stocks like SANM and MGX where 30-day win rates exceed shorter timeframes, suggesting fundamental strength.

Risk Management: Biotech stocks (XCUR, SCYX, DMAC) require position sizing discipline due to high volatility and regulatory risks.

Sector Diversification: ETFs like WCBR and CIBR provide safer exposure to trending sectors without single-stock concentration risk.

Caution Zones: Stocks with declining win rates over longer timeframes (like STRL's 35% at 30D) may face fundamental headwinds despite short-term momentum.